BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yasuzaki H, Yoshida S, Hashimoto T, Shibata W, Inamori M, Toya Y, Tamura K, Maeda S, Umemura S. Involvement of the apelin receptor APJ in Fas-induced liver injury. Liver Int 2013;33:118-26. [PMID: 23121371 DOI: 10.1111/liv.12006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Fan X, Xue F, Zhang Y, Xing X, Liu H, Mao S, Kong X, Gao Y, Liu SF, Gong Y. The Apelin-APJ Axis Is an Endogenous Counterinjury Mechanism in Experimental Acute Lung Injury. Chest 2015;147:969-78. [DOI: 10.1378/chest.14-1426] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yu X, Tang Z, Liu L, Qian H, Tang S, Zhang D, Tian G, Tang C. Apelin and its receptor APJ in cardiovascular diseases. Clinica Chimica Acta 2014;428:1-8. [DOI: 10.1016/j.cca.2013.09.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 8.8] [Reference Citation Analysis]
3 Vafaee F. Using Multi-objective Optimization to Identify Dynamical Network Biomarkers as Early-warning Signals of Complex Diseases. Sci Rep 2016;6:22023. [PMID: 26906975 DOI: 10.1038/srep22023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
4 Castan-Laurell I, Masri B, Valet P. The apelin/APJ system as a therapeutic target in metabolic diseases. Expert Opin Ther Targets 2019;23:215-25. [PMID: 30570369 DOI: 10.1080/14728222.2019.1561871] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
5 Lv SY, Cui B, Chen WD, Wang YD. Apelin/APJ system: A key therapeutic target for liver disease. Oncotarget. 2017;8:112145-112151. [PMID: 29340118 DOI: 10.18632/oncotarget.22841] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gonçalves-de-Albuquerque CF, Silva AR, Burth P, Castro-Faria MV, Castro-Faria-Neto HC. Acute Respiratory Distress Syndrome: Role of Oleic Acid-Triggered Lung Injury and Inflammation. Mediators Inflamm 2015;2015:260465. [PMID: 26640323 DOI: 10.1155/2015/260465] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
7 Huang Z, Luo X, Liu M, Chen L. Function and regulation of apelin/APJ system in digestive physiology and pathology. J Cell Physiol 2019;234:7796-810. [PMID: 30390294 DOI: 10.1002/jcp.27720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
8 Huang Z, He L, Chen Z, Chen L. Targeting drugs to APJ receptor: From signaling to pathophysiological effects. J Cell Physiol 2019;234:61-74. [DOI: 10.1002/jcp.27047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
9 Bertrand C, Pradère JP, Geoffre N, Deleruyelle S, Masri B, Personnaz J, Le Gonidec S, Batut A, Louche K, Moro C, Valet P, Castan-Laurell I. Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism. Endocrine 2018;60:112-21. [PMID: 29392617 DOI: 10.1007/s12020-018-1536-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ji W, Shi H, Shen H, Kong J, Song J, Bian H, Lv X. Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling. Oxid Med Cell Longev 2019;2019:6140360. [PMID: 31687083 DOI: 10.1155/2019/6140360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Melgar-Lesmes P, Perramon M, Jiménez W. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells 2019;8:E1311. [PMID: 31653030 DOI: 10.3390/cells8111311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
12 Antushevich H, Wójcik M. Review: Apelin in disease. Clin Chim Acta 2018;483:241-8. [PMID: 29750964 DOI: 10.1016/j.cca.2018.05.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
13 Tan W, Zheng H, Wang D, Tian F, Li H, Liu X. Expression characteristics and regulatory mechanism of Apela gene in liver of chicken (Gallus gallus). PLoS One 2020;15:e0238784. [PMID: 32915867 DOI: 10.1371/journal.pone.0238784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Yoshiya S, Shirabe K, Imai D, Toshima T, Yamashita Y, Ikegami T, Okano S, Yoshizumi T, Kawanaka H, Maehara Y. Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol 2015;50:573-82. [PMID: 25148722 DOI: 10.1007/s00535-014-0992-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
15 Xu J, Chen L, Jiang Z, Li L. Biological functions of Elabela, a novel endogenous ligand of APJ receptor. J Cell Physiol. 2018;233:6472-6482. [PMID: 29350399 DOI: 10.1002/jcp.26492] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
16 Lv X, Kong J, Chen WD, Wang YD. The Role of the Apelin/APJ System in the Regulation of Liver Disease. Front Pharmacol 2017;8:221. [PMID: 28484393 DOI: 10.3389/fphar.2017.00221] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
17 Wang Y, Song J, Bian H, Bo J, Lv S, Pan W, Lv X. Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. Mol Cell Biochem. 2019;460:205-215. [PMID: 31270645 DOI: 10.1007/s11010-019-03581-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]